CIK 0000882095
- Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943047598
- Phone
- +1 650-574-3000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $36,996,096
- in 12 filings, $37.0M under 10b5-1 plans
Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-25 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise | +514 | 7,276 | ||
| 2024-01-25 | Telman Deborah H EVP, Corporate Affairs & GC | Shares withheld for taxes | −194 | $80.23 | $16K | 7,082 |
| 2024-01-25 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise · Restricted Stock Unit | −514 | 31,823 | ||
| 2024-01-16 | Dickinson Andrew D Chief Financial Officer | Sale 10b5-1 | −5,000 | $85.78 | $429K | 101,534 |
| 2024-01-09 | Mercier Johanna Chief Commercial Officer | Sale 10b5-1 | −8,242 | $85.23 | $702K | 82,729 |
| 2023-12-28 | Lofton Kevin E Director | Grant or award · Phantom Stock | +29.53 | 3,224.25 | ||
| 2023-12-13 | Patterson Sandra SVP, Controllership | Option exercise | +181 | 37,259 | ||
| 2023-12-13 | Patterson Sandra SVP, Controllership | Option exercise | +117 | 37,376 | ||
| 2023-12-13 | Patterson Sandra SVP, Controllership | Shares withheld for taxes | −298 | $83.09 | $25K | 37,235 |
| 2023-12-13 | Patterson Sandra SVP, Controllership | Option exercise · Restricted Stock Unit | −181 | 12,101 | ||
| 2023-12-13 | Patterson Sandra SVP, Controllership | Option exercise · Restricted Stock Unit | −117 | 11,984 | ||
| 2023-12-10 | Mercier Johanna Chief Commercial Officer | Option exercise | +2,730 | 92,218 | ||
| 2023-12-10 | Mercier Johanna Chief Commercial Officer | Shares withheld for taxes | −1,247 | $79.02 | $99K | 90,971 |
| 2023-12-10 | Mercier Johanna Chief Commercial Officer | Option exercise · Restricted Stock Unit | −2,730 | 39,987 | ||
| 2023-12-10 | Parsey Merdad Chief Medical Officer | Option exercise | +2,779 | 72,909 | ||
| 2023-12-10 | Parsey Merdad Chief Medical Officer | Shares withheld for taxes | −1,269 | $79.02 | $100K | 71,640 |
| 2023-12-10 | Parsey Merdad Chief Medical Officer | Option exercise · Restricted Stock Unit | −2,779 | 40,975 | ||
| 2023-12-10 | Patterson Sandra SVP, Controllership | Option exercise | +518 | 30,642 | ||
| 2023-12-10 | Patterson Sandra SVP, Controllership | Shares withheld for taxes | −222 | $79.02 | $18K | 30,420 |
| 2023-12-10 | Patterson Sandra SVP, Controllership | Option exercise · Restricted Stock Unit | −518 | 16,520 |
Page 31 of 43 · 851 trades